Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Scorpius Holdings ( (SCPX) ) has shared an update.
On January 16, 2025, Scorpius Holdings’ stockholders approved a reverse stock split proposal at a 1-for-20 ratio to comply with NYSE American listing standards. This move, effective on January 21, 2025, aims to increase the company’s stock price, ensuring continued compliance with exchange requirements. The reverse stock split does not alter stockholders’ ownership percentages, except for fractional shares, which will be compensated in cash.
More about Scorpius Holdings
Scorpius Holdings, Inc. is an integrated contract development and manufacturing organization (CDMO) focused on advancing biologic programs to clinical stages. The company provides analytical testing, process development, and manufacturing services to pharmaceutical and biotech firms from its facilities in San Antonio, TX.
YTD Price Performance: 7.06%
Average Trading Volume: 1,976,415
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $1.83M
For an in-depth examination of SCPX stock, go to TipRanks’ Stock Analysis page.
